<?xml version="1.0" encoding="UTF-8"?>
<ref id="R12">
 <label>12</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Douillard</surname>
    <given-names>J-Y</given-names>
   </name>, 
   <name name-style="western">
    <surname>Rosell</surname>
    <given-names>R</given-names>
   </name>, 
   <name name-style="western">
    <surname>De Lena</surname>
    <given-names>M</given-names>
   </name>, 
   <etal>et al</etal>
  </person-group>
  <article-title>Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial</article-title>. 
  <source>Lancet Oncol</source>
  <year>2006</year>;
  <volume>7</volume>:
  <fpage>719</fpage>â€“
  <lpage>27</lpage>. 
  <pub-id pub-id-type="doi">10.1016/S1470-2045(06)70804-X</pub-id>
  <?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/16945766?>
  <pub-id pub-id-type="pmid">16945766</pub-id>
 </mixed-citation>
</ref>
